Sarclisa (isatuximab)

pCPA File Number: 21752
Negotiation Status:
Active Negotiation
Indication(s):
In combination with carfilzomib and dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma who have received 1 to 3 prior lines of therapy
Sponsor/Manufacturer:
Sanofi Genzyme
CADTH Project Number:
PC0256
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable